OMX Nordic 40
2.111,40
PKT
-8,25
PKT
-0,39
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
10.04.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
10.04.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
10.04.25 | AstraZeneca Buy | UBS AG | |
09.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
09.04.25 | AstraZeneca Outperform | Bernstein Research | |
08.04.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
08.04.25 | Nokia Buy | Deutsche Bank AG | |
08.04.25 | Nokia Market-Perform | Bernstein Research | |
08.04.25 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Bernstein Research | |
08.04.25 | Novo Nordisk Buy | UBS AG | |
07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
07.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
04.04.25 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
03.04.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
03.04.25 | AstraZeneca Outperform | Bernstein Research | |
03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
03.04.25 | Volvo (B) Underperform | Bernstein Research | |
03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
03.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.04.25 | AstraZeneca Buy | UBS AG | |
01.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
01.04.25 | Volvo (B) Underperform | Bernstein Research | |
31.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
28.03.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
27.03.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
27.03.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
27.03.25 | Volvo (B) Buy | Jefferies & Company Inc. |